However, aqueous ApoB100 levels were significantly higher in patients with early and intermediate nnvAMD compared with patients with nvAMD (Figure 8A), suggesting that ApoB100 levels decrease with progression from dry to wet AMD. This evidence concerns the gene APOB and age-related macular degeneration.